EP3313818
METHODS FOR THE TREATMENT OF KAPOSI'S SARCOMA OR KSHV-INDUCED LYMPHOMA USING IMMUNOMODULATORY COMPOUNDS, AND USES OF BIOMARKERS
:
EP einkaleyfi: Þýðing ekki lögð inn:
24.6.2016:
8.11.2023:
16815375.7
:
23.6.2036
:
METHODS FOR THE TREATMENT OF KAPOSI'S SARCOMA OR KSHV-INDUCED LYMPHOMA USING IMMUNOMODULATORY COMPOUNDS, AND USES OF BIOMARKERS
24.6.2016
8.11.2023
:
Celgene Corporation:
86 Morris Avenue, Summit, NJ 07901, US
:
The U.S.A. as represented by the Secretary, Department of Health and Human Services:
Office of Technology Transfer National Institutes of Health 6011 Executive Boulevard, Suite 325 MSC 7660, Bethesda, MD 20892-7660, US
:
YARCHOAN, Robert:
Bethesda, MD 20817, US
:
ZELDIS, Jerome:
Princeton, NJ 08540, US
:
POLIZZOTTO, Mark:
Paddington, New South Wales 2021, AU
:
DAVIS, David:
Bethesda, MD 20817, US
:
SERETI, Irini:
Washington, DC 20004, US
:
ULDRICK, Thomas:
Washington, DC 20005, US
:
WHITBY, Denise:
Frederick, MD 21701, US
:
KHETANI, Vikram:
Short Hills, NJ 07078, US
:
201562185265 P:
26.6.2015:
US
:
US2016039245:
24.6.2016
:
C07D 209/48, A61K 31/404, A61K 45/06, C07D 471/04, C07D 473/34, A61P 35/00